Tag Archives: OMER

A Director at Omeros is Exercising Options

Yesterday it was reported that a Director at Omeros (OMER – Research Report), Leroy Phd Hood, exercised options to buy 10,000 OMER shares at $7.56 a share, for a total transaction value of $75.6K. The options were close to expired

Maxim Group Sticks to Its Buy Rating for Omeros (OMER)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Omeros (OMER – Research Report) yesterday and set a price target of $25.00. The company’s shares closed last Monday at $13.24. According to TipRanks.com, McCarthy has 0 stars on 0-5

Needham Maintains a Hold Rating on Omeros (OMER)

Needham analyst Serge Belanger maintained a Hold rating on Omeros (OMER – Research Report) today. The company’s shares closed last Monday at $15.21. According to TipRanks.com, Belanger is a 3-star analyst with an average return of 1.9% and a 44.9%

Sunday’s Highlights at Noon: Teva Pharmaceutical Industries (TEVA), UnitedHealth (UNH), Ebix (EBIX), Omeros (OMER), Cormedix (CRMD)

So far Sunday, November 17, NASDAQ is up 0.17% and the S&P is up 0.77%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Teva Pharmaceutical Industries (TEVA – Research Report), UnitedHealth (UNH –

Omeros (OMER) Receives a Hold from Wedbush

Wedbush analyst Liana Moussatos reiterated a Hold rating on Omeros (OMER – Research Report) today and set a price target of $18.00. The company’s shares closed last Monday at $13.20. According to TipRanks.com, Moussatos has 0 stars on 0-5 star

Needham Remains a Hold on Omeros (OMER)

Needham analyst Serge Belanger maintained a Hold rating on Omeros (OMER – Research Report) today. The company’s shares closed last Monday at $13.70. According to TipRanks.com, Belanger is a 1-star analyst with an average return of -1.4% and a 39.8%